50-32-607. Authorization for possession and administration of opioid antagonist -- reporting -- immunity related to expired opioid antagonist, MCA

Montana Code Annotated 2025

TITLE 50. HEALTH AND SAFETY

CHAPTER 32. CONTROLLED SUBSTANCES

Part 6. Help Save Lives From Overdose Act

Authorization For Possession And Administration Of Opioid Antagonist -- Reporting -- Immunity Related To Expired Opioid Antagonist

50-32-607. Authorization for possession and administration of opioid antagonist -- reporting -- immunity related to expired opioid antagonist. (1) An eligible recipient to whom an opioid antagonist is prescribed, dispensed, or distributed pursuant to 50-32-604 through 50-32-606 and who has received the instruction and information provided for in 50-32-606 may do any of the following:

(a) possess and store the opioid antagonist. The storage of an opioid antagonist is not subject to pharmacy practice laws or other requirements that apply to the storage of drugs or medications.

(b) in good faith, administer or direct another person to administer the opioid antagonist to a person who is experiencing an actual or reasonably perceived opioid-related drug overdose;

(c) distribute the opioid antagonist to a person who is an eligible recipient under 50-32-603(5)(a) or (5)(b); and

(d) possess, store, administer, direct another person to administer, or distribute an expired opioid antagonist.

(2) An eligible recipient to whom an opioid antagonist is dispensed pursuant to 50-32-604 through 50-32-606 shall report, if required by the department, information regarding the dispensing, distribution, and administration of the opioid antagonist.

(3) A person who engages in the activities authorized in subsection (1) is not liable for injury or damages caused by possessing, storing, administering, or directing another person to administer, or distributing an expired opioid antagonist, except for injury or damages arising from gross negligence, willful or wanton misconduct, or an intentional tort.

History: En. Sec. 7, Ch. 253, L. 2017; amd. Sec. 3, Ch. 581, L. 2025.